Generics - Generics, Women's Health


Current filters:

GenericsWomen's Health

Popular Filters

Mylan settles over generic Generess tablets and launches insomnia drug

Mylan settles over generic Generess tablets and launches insomnia drug


US generics major Mylan (Nasdaq: MYL) and its partner Famy Care have entered into a settlement and license…

ActavisFamy CareGeneress FeGenericsHealth Medical PharmaLegalLunestaMylanMylan LaboratoriesPharmaceutical sciencesPharmacologyUSAWomen's Health

US FDA approves NDA from Actavis and Valeant

US FDA approves NDA from Actavis and Valeant


US generics major Actavis and Canada’s Valeant Pharmaceuticals said that the US Food and Drug Administration…

ActavisCanadaGenericsMetronidazolePharmaceuticalRegulationUSAValeant PharmaceuticalsWomen's Health

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'


Actavis has agreed to sell all rights and assets to four generic pharmaceuticals to settle US Federal…

ActavisAmneal PharmaAtelviaFemcon FeGenericsLegalLoestrin 24 FeMergers & AcquisitionsWarner ChilcottWomen's Health

Prescription painkiller overdoses has risen 400% in women, says the US CDC


Women in the USA are dying from prescription painkiller overdoses at rates never seen before, according…

Endo Health SolutionsGenericsHealthcareMethadoneOpanaOxyContinPurdue PharmaResearchVicodinWomen's Health

Actavis confirms patent challenge on Bayer's Safyral


USA-based generics major Actavis (NYSE: ACT) yesterday (June 5) confirmed that it has filed an Abbreviated…

ActavisBayerGenericsPatentsRegulationReproductiveSafyralWomen's Health

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal


US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Watson acquires Uteron Pharma; confirms Opana patent challenge


US generic and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) says that it has completed the…

Endo PharmaceuticalsGenericsGrunenthalMergers & AcquisitionsNeurologicalNorth AmericaOpanaPatentsPharmaceuticalUteron PharmaWatson PharmaceuticalsWomen's Health

Depomed to file NDA for Serada; with Valeant sues Watson over Glumetza


US drugmaker Depomed (Nasdaq: DEPO) says that it has completed a Type B pre-New Drug Application meeting…

DepomedDiabetesGenericsGlumetzaNorth AmericaPatentsPharmaceuticalRegulationResearchSeradaValeant PharmaceuticalsWatson PharmaceuticalsWomen's Health

Watson settles with Janssen over Ortho Tri-Cyclen LO


US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA


US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by…

CaduetCardio-vascularGeneress FeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPfizerReproductiveWarner ChilcottWomen's Health

Company Spotlight



Back to top